Non-Invasive Prenatal Testing (NIPT) Market Worth $5.5 Billion by 2025: Grand View Research, Inc.

    
SAN FRANCISCO, (informazione.it - comunicati stampa - salute e benessere)

    

In addition, presence of players such as Anthem and Blue Shield of California that have endorsed cfDNA-based Noninvasive Prenatal Testing (NIPT) for trisomies 13, 18, and 21 is expected to impact the adoption rate of these tests, thereby resulting in increased revenue generation.

However, the projected NIPT-related price erosion in this market is expected to continue, thus intensifying competition amongst the operating participants, but restraining revenue generation to a certain extent.

Browse full research report with TOC on"Non-Invasive Prenatal Testing Market Analysis by Gestation Period (0-12 weeks, 13-24 weeks, 25-36 weeks), by Pregnancy Risk Level (High & Average Risk, Low Risk), By Region (U.S., UK, Germany, Japan, China, Brazil)And Segment Forecasts, 2014 - 2025" at:http://www.grandviewresearch.com/industry-analysis/noninvasive-prenatal-testing-market

Further Key Findings from the Report Suggest: 

Browse related reports by Grand View Research: 

Non-Invasive Prenatal Testing (NIPT) Market Worth $5.5 Billion by 2025: Grand View Research, Inc.

Grand View Research has segmented the NIPT market on the basis of gestation period, and pregnancy risk level: 

Access research insight:http://www.grandviewresearch.com/research-insights/non-invasive-prenatal-testing-market-insights-size-share

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Read Our Blogs-http://www.grandviewresearch.com/blogs/healthcare

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]

Web: http://www.grandviewresearch.com  

Ufficio Stampa
 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
Allegati
Slide ShowSlide Show
Non disponibili